-
The November Newsletter announces the incredible findings of study A5349 regarding a shortened 4-month regimen for the treatment of drug-susceptible…
-
The October Newsletter is dedicated to the hard work of the ACTG investigators, advocates, and community members. It features a…
-
The September Newsletter honors the memory of our ACTG colleague David Hughes. It announced the first enrollment into study A5401/ACTIV-2,…
-
The August Newsletter announces the opening of A5401/ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial and shares the REPRIEVE studies…
-
The July Newsletter highlights the abstracts that will be presented at AIDS 2020 and announces ACTG’s participation in A5401 and…
-
The June Newsletter features a note from ACTG Leadership about the current state of our country and the ACTG’s commitment…
-
The May Newsletter highlights just some of the many efforts of the ACTG Network as focus is pivoted to COVID-19.…
-
The March newsletter features previews of the 28 ACTG abstracts chosen to be presented at the Conference of Opportunistic Infections…
-
The February newsletter announced the launch of the page “They Became My Family,” highlighting the profiles of some of our…
-
A note from Dr. Currier and Dr. Eron about the past year.
-
The December newsletter announced the launch of our new ACTG website! It also featured a moving piece by Vice Chair,…
-
The November newsletter announced that study A5381 has opened and summarized publications relating to studies A5208, A5321, and A5001. It…
HANC NEWSLETTER
Check Out News From The Office Of HIV/AIDS Network Coordination (HANC)